STAGE IB BREAST CANCER
Clinical trials for STAGE IB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Time radiation boost during breast surgery shows promise in Early-Stage cancer trial
Disease control OngoingThis study tests whether giving a single dose of radiation directly to the tumor site during breast-conserving surgery (lumpectomy) and before reconstruction is safe and effective for women with early-stage breast cancer. About 108 participants with stage I-II breast cancer will …
Matched conditions: STAGE IB BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could adding carboplatin to chemo keep triple-negative breast cancer away?
Disease control OngoingThis phase 3 trial tests whether adding the drug carboplatin to standard chemotherapy (doxorubicin, cyclophosphamide, and paclitaxel) helps prevent triple-negative breast cancer from coming back. About 782 patients with high-risk or node-positive disease are participating. The st…
Matched conditions: STAGE IB BREAST CANCER
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a one-week radiation zap be just as good as three weeks for early breast cancer?
Disease control OngoingThis study compares a 1-week radiation schedule to the standard 3.1-week schedule for people with early-stage breast cancer who have had lumpectomy. The goal is to see if the shorter course controls cancer just as well while causing fewer side effects. About 72 adults with ductal…
Matched conditions: STAGE IB BREAST CANCER
Phase: NA • Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC